Nearology, page-2

LBT certainly was a glimpse into what is possible when FDA approval is granted , reading their tech I can't help but think it's not as much a disrupter as epat or rap tech and certainly not as easy for people to understand what it is

You can also see why the sustained buyers are in rap since not holding the stock when they get regulatory approval is probably the feeling of LBT sellers prior to today

With regulatory approval first in Aust as a performance milestone within next 12 months it won't take long to realise value and of course the question will be how long will it take, 4 , 6,9 or 12 months ???